Biofrontera Community

Key Takeaways Expansion of Ameluz indications, improved reimbursement, and patent extension are set to drive revenue growth and strengthen market position amid rising skin cancer rates. Reduced costs due to lower royalties and focus on new dermatological indications are expected to improve margins and enable future product launches.